← FDA Drug Approvals (Drugs@FDA)

ARIPIPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QUAGEN · Approved 2025-10-22

Drug application

FDA Application #

ANDA215582

Application type

Abbreviated New Drug Application (Generic)

Brand name

ARIPIPRAZOLE

Generic name

ARIPIPRAZOLE

Active ingredients

ARIPIPRAZOLE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

QUAGEN

Manufacturer

QUAGEN PHARMACEUTICALS LLC

First approval

2025-10-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown